Showing results (91-100 of 267) with videos related to

Sort By:
Pageof 27
Human Reproduction (Oxford, England)|July 26, 2011
Impact of CCN3 (NOV) glycosylation on migration/invasion properties and cell growth of the choriocarcinoma cell line Jeg3Wei Yang, Jessica Wagener, Nadine Wolf, et al.
BMC Cancer|August 2, 2012
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survivalJan Dominik Kuhlmann, Heidi Schwarzenbach, Pauline Wimberger, et al.
BMC Pregnancy and Childbirth|September 15, 2023
Cervical ectopic pregnancy - the first case of live birth and uterus-conserving managementAngela Köninger, Buu-Phuc Nguyen, Udo Schwenk, et al.
Journal of Cancer Research and Clinical Oncology|June 24, 2003
Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cellsWei Xiang, Pauline Wimberger, Torsten Dreier, et al.
Journal of Clinical Medicine|September 10, 2021
Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease-A Meta-AnalysisRaluca I Mincu, Lena F Lampe, Amir A Mahabadi, et al.
Breast Cancer Research : BCR|September 24, 2009
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancerHeidi Schwarzenbach, Klaus Pantel, Birthe Kemper, et al.
Breast Cancer Research and Treatment|March 24, 2009
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomasFriedrich Otterbach, Rainer Callies, Michael Adamzik, et al.
European Journal of Endocrinology|February 3, 2006
Decreased soluble leptin receptor levels in women with polycystic ovary syndromeSusanne Hahn, Uwe Haselhorst, Beate Quadbeck, et al.
Gynecologic Oncology|October 4, 2005
Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)Pauline Wimberger, Nils Lehmann, Rainer Kimmig, et al.
Future Science OA|January 25, 2017
Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancerPaul Buderath, Sabine Kasimir-Bauer, Bahriye Aktas, et al.
Pageof 27